{
    "2025-03-31": {
        "Tax Effect Of Unusual Items": 0.0,
        "Tax Rate For Calcs": 0.095745,
        "Normalized EBITDA": 100400000.0,
        "Total Unusual Items": NaN,
        "Total Unusual Items Excluding Goodwill": NaN,
        "Net Income From Continuing Operation Net Minority Interest": 51000000.0,
        "Reconciled Depreciation": 26900000.0,
        "Reconciled Cost Of Revenue": 238400000.0,
        "EBITDA": 100400000.0,
        "EBIT": 73500000.0,
        "Net Interest Income": -16600000.0,
        "Normalized Income": 51000000.0,
        "Net Income From Continuing And Discontinued Operation": 51000000.0,
        "Total Expenses": 408300000.0,
        "Total Operating Income As Reported": 73500000.0,
        "Diluted NI Availto Com Stockholders": 51000000.0,
        "Net Income Common Stockholders": 51000000.0,
        "Net Income": 51000000.0,
        "Net Income Including Noncontrolling Interests": 51000000.0,
        "Net Income Continuous Operations": 51000000.0,
        "Tax Provision": 5400000.0,
        "Pretax Income": 56400000.0,
        "Other Income Expense": -500000.0,
        "Other Non Operating Income Expenses": -500000.0,
        "Special Income Charges": NaN,
        "Gain On Sale Of Ppe": NaN,
        "Net Non Operating Interest Income Expense": -16600000.0,
        "Total Other Finance Cost": 16600000.0,
        "Operating Income": 73500000.0,
        "Operating Expense": 169900000.0,
        "Research And Development": 41300000.0,
        "Selling General And Administration": 128600000.0,
        "Gross Profit": 243400000.0,
        "Cost Of Revenue": 238400000.0,
        "Total Revenue": 481800000.0,
        "Operating Revenue": 481800000.0
    },
    "2024-03-31": {
        "Tax Effect Of Unusual Items": 11024573.863636,
        "Tax Rate For Calcs": 0.174716,
        "Normalized EBITDA": 44300000.0,
        "Total Unusual Items": 63100000.0,
        "Total Unusual Items Excluding Goodwill": 63100000.0,
        "Net Income From Continuing Operation Net Minority Interest": 116200000.0,
        "Reconciled Depreciation": 29400000.0,
        "Reconciled Cost Of Revenue": 265300000.0,
        "EBITDA": 107400000.0,
        "EBIT": 78000000.0,
        "Net Interest Income": NaN,
        "Normalized Income": 64124573.863636,
        "Net Income From Continuing And Discontinued Operation": 116200000.0,
        "Total Expenses": 463200000.0,
        "Total Operating Income As Reported": 141100000.0,
        "Diluted NI Availto Com Stockholders": 116200000.0,
        "Net Income Common Stockholders": 116200000.0,
        "Net Income": 116200000.0,
        "Net Income Including Noncontrolling Interests": 116200000.0,
        "Net Income Continuous Operations": 116200000.0,
        "Tax Provision": 24600000.0,
        "Pretax Income": 140800000.0,
        "Other Income Expense": 62800000.0,
        "Other Non Operating Income Expenses": -300000.0,
        "Special Income Charges": 63100000.0,
        "Gain On Sale Of Ppe": 63100000.0,
        "Net Non Operating Interest Income Expense": NaN,
        "Total Other Finance Cost": NaN,
        "Operating Income": 78000000.0,
        "Operating Expense": 197900000.0,
        "Research And Development": 42700000.0,
        "Selling General And Administration": 155200000.0,
        "Gross Profit": 275900000.0,
        "Cost Of Revenue": 265300000.0,
        "Total Revenue": 541200000.0,
        "Operating Revenue": 541200000.0
    }
}